Comparison of the analgesic effect of Xeomin injection at 10 points of the scalp with injection at 31 points of the scalp on pain intensity in patients with chronic migraine
Latest Information Update: 01 Dec 2020
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 01 Dec 2020 New trial record